QUOTE : only a remote possibility in the United States, since existing reproductive procedures such as IVF and PGD, which routinely cost tens of thousands of dollars, are seldom covered by health insurance. But in places like France, Israel, and Sweden, countries whose national health plans cover assisted reproduction, it’s possible that simple economics will incentivize governments to make gene editing available to patients who need it. After all, providing lifelong treatment to a single person with a genetic disease could be much more expensive than prophylactic intervention in the embryo using gene editing.